Page 30 - Katten 2019 Annual Review
P. 30

28   Katten              Practice Areas

        Practice Areas





        Antitrust and Competition            Government and Public Finance        Privacy, Data and Cybersecurity
        Antitrust and Competition Litigation  Health Care                         Private Wealth
        Mergers and Acquisitions             Infrastructure and P3                Business Succession Planning
        Commercial Finance                   Insolvency and Restructuring         Charitable Planning, Philanthropy and
        Restaurant and Franchise Finance     Intellectual Property                 Nonprofit Organizations
        Corporate                            Advertising, Marketing and Promotions  Fiduciary Litigation
                                                                                  Private Client Services
        Corporate Governance                 Intellectual Property Litigation
        Corporate Securities                 Patent Litigation and Patents        Real Estate
        Distressed Debt and Claims Trading   Pharmaceutical and Life Sciences     Affordable Housing and Community
        Education Private Equity              Litigation                           Development
        Entrepreneurial Ventures             Trademark Licensing and Strategy     Commercial Mortgage-Backed Securities
        Independent Sponsors                 Trademarks and Trademark Litigation  Private Equity and Real Estate Fund
        Insurance Private Equity             International                         Formation
        Manufacturing and Industrials        China                                Real Estate Acquisitions, Dispositions
         Private Equity                      United Kingdom                        and Joint Ventures
        Mergers and Acquisitions             UK Real Estate                       Real Estate Development
        Private Equity                                                            Real Estate Finance and Lending
        Private Equity and Real Estate       Litigation                           Real Estate Litigation
         Fund Formation                      Antitrust and Competition Litigation  UK Real Estate
        Private Equity Regulatory Compliance  Appeals and Critical Motions        Structured Finance and Securitization
        Employee Benefits and Executive      Class Action/Consumer Finance        Transactional Tax Planning
                                              Litigation
        Compensation                         Commercial Litigation
        Executive Compensation and Employee    Electronic Discovery and Information
         Benefits in Corporate Transactions   Governance
        Retirement Plan Governance, Invest-  Employment Litigation and Counseling
         ment and Asset Management           Entertainment and Media Litigation
        Health and Welfare and Fringe Benefit   Fiduciary Litigation
         Plan Compliance, Administration     Financial Markets Litigation and
         and Funding                          Enforcement
        Financial Markets and Funds          Foreign Corrupt Practices Act Litigation
        Broker-Dealer Regulation             Health Care Litigation, Reimburse-
        Distressed Debt and Claims Trading    ment and Regulation
        Distributed Ledger Products, Services   Insurance and Health Care Fraud
         and Technology                       Litigation
        Financial Markets Litigation and     Intellectual Property Litigation
         Enforcement                         Monitorships
        Futures and Derivatives              Patent Litigation and Patents
        Insurance Products and Regulation    Pharmaceutical and Life Sciences
        Investment Companies                  Litigation
        Private Funds and Investment         Real Estate Litigation
         Management                          Securities Litigation
        Proprietary Trading Firms            Trademarks and Trademark Litigation
        Quantitative and Algorithmic Trading  White Collar and Internal Investigations
        Structured Products
   25   26   27   28   29   30   31   32